Christopher M. Oermann
Baylor College of Medicine
Houston
Texas
USA
Name/email consistency: high
- An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Oermann, C.M., Retsch-Bogart, G.Z., Quittner, A.L., Gibson, R.L., McCoy, K.S., Montgomery, A.B., Cooper, P.J. Pediatr. Pulmonol. (2010)
- The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. Oermann, C.M., Sockrider, M.M., Konstan, M.W. Chest (1999)









